Reference-grade research compound
Tirzepatide
Synthetic 39-residue dual GIP/GLP-1 receptor agonist peptide with Aib substitutions and a C20 fatty diacid conjugated at Lys20 via a γGlu-(2x AEEA) linker
Loading 3D structure…
PDB 7RG9
- Scientific name
- Synthetic 39-residue dual GIP/GLP-1 receptor agonist peptide with Aib substitutions and a C20 fatty diacid conjugated at Lys20 via a γGlu-(2x AEEA) linker
- Sequence
- —
- Length
- 39-mer
- Molecular formula
- C225H348N48O68
- Molecular weight
- 4813.45 g/mol
- Form
- lyophilized
- Available sizes
- 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, 25 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg, 80 mg, 90 mg, 100 mg, 110 mg, 120 mg, 2.5 mg · cartridge (no pen), 5 mg · cartridge (no pen), 10 mg · cartridge (no pen), 15 mg · cartridge (no pen)
- Storage
- Store lyophilized powder at −20 °C, desiccated and protected from light. Stable for 24 months.
- Batch HPLC purity
- 99.0%
Description
Synthetic 39-residue incretin-mimetic peptide containing non-natural aminoisobutyric acid residues and a C20 fatty diacid side chain. Used in vitro as a reference compound in GIP and GLP-1 receptor binding and cAMP accumulation assays in transfected cell-line model systems. Supplied as a lyophilized acetate salt.
Storage and stability
Store lyophilized powder at −20 °C, desiccated and protected from light. Stable for 24 months.
Peer-reviewed references
Titles and journals pulled from PubMed and cached for 7 days. Links open in a new tab.